Tech Company Financing Transactions

Tranquis Therapeutics Funding Round

Tranquis Therapeutics closed a $30 million Series A investment round on 7/10/2020. Backers included Remiges Ventures, SR One Capital Management and Correlation Ventures.

Transaction Overview

Company Name
Tranquis Therapeutics
Announced On
7/10/2020
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors

Remiges Ventures (Lead Investor) (Taro Inaba)

SR One Capital Management (Lead Investor) (Rajeev Dadoo)

Correlation Ventures

Hillsborough Venture

Vivo Capital (Edgar Engleman)

Proceeds Purpose
With the support of our investors and proceeds from the Series A financing, we plan to complete the non-clinical development work for our pipeline program, TQS-168, and advance it toward clinical proof of concept in orphan diseases such as ALS or FTD, while further expanding our discovery platform and pipeline with next generation compounds.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
951 Mariners Island Blvd. 300
San Mateo, CA 94404
USA
Phone
(650) 684-8950
Website
www.tranquis.com
Email Address
[email protected]
Overview
Founded on groundbreaking immuno-neurology research by Tranquis' scientific founder, Dr. Edgar Engleman, and his team at Stanford, we are discovering and developing a novel portfolio of small molecule therapeutic candidates which cross the blood-brain barrier to target the underlying myeloid immune cell dysfunction that has been linked to a variety of nervous system disorders.
Profile
Tranquis Therapeutics LinkedIn Company Profile
Social Media
Tranquis Therapeutics Company Twitter Account
Company News
Tranquis Therapeutics News
Facebook
Tranquis Therapeutics on Facebook
YouTube
Tranquis Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sanjay Kakkar
  Sanjay Kakkar LinkedIn Profile  Sanjay Kakkar Twitter Account  Sanjay Kakkar News  Sanjay Kakkar on Facebook
VP - Bus. Development
Titus Plattel
  Titus Plattel LinkedIn Profile  Titus Plattel Twitter Account  Titus Plattel News  Titus Plattel on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/10/2020: Swiftmile venture capital transaction
Next: 7/10/2020: Docket venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.